Sparked by the sequencing of the human genome a decade ago, a new generation of prenatal screening tests has exploded onto the market. The unregulated screens claim to detect with near-perfect accuracy the risk that a fetus may have Down syndrome and a growing list of other chromosomal abnormalities. Hundreds of thousands of women in early pregnancy have taken these tests, but a three-month examination by the New England Center for Investigative Reporting has found that companies are overselling the accuracy of their tests and doing little to educate expecting parents or their doctors about the significant risks of false alarms. Michael Greene, professor of obstetrics, gynecology and reproductive biology at Massachusetts General Hospital, is quoted.
Trending News
Children Are Left Out of Medical AI. A New Method Could Help.
Adult radiology models can be adapted for newborns without data leaving hospitals
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease